Answers are grounded in this paper and cite their sources.
CONTEXT: Although residual beta-cell function delays the onset and progression of diabetic retinopathy in patients with type 1 diabetes, the rate of beta-cell destruction is variable. OBJECTIVE: The aim of the study was to clarify the influence of the rate of beta-cell destruction on the development and progression of diabetic retinopathy in type 1 diabetes. DESIGN: We performed a historical cohort study regarding residual beta-cell function and retinopathy. SETTING: The study was conducted in the outpatient clinic of a general hospital. PATIENTS: A total of 254 patients with type 1 diabetes participated. MAIN OUTCOME MEASURES: Serum C-peptide and fundus findings were evaluated longitudinally. RESULTS: The cumulative incidence of mild nonproliferative diabetic retinopathy was higher in the patients without detectable beta-cell function than in those with residual beta-cell function at 20, 15, and 10 yr after the onset of diabetes (P = 0.013, P = 0.006, and P = 0.048, respectively), but not at 5 yr after the onset (P = 0.84). There were higher mean glycosylated hemoglobin values during the entire follow-up period in the patients without detectable beta-cell function at 20 and 15 yr after the onset of diabetes (P = 0.030 and P = 0.042, respectively). Positivity for HLA-A24 and -DQA1 03, as well as the acute onset of diabetes, was associated with early beta-cell loss and also with early development of diabetic retinopathy. Cox proportional hazards analysis showed that undetectable beta-cell function at 20, 15, or 10 yr after the onset of diabetes was an independent risk factor for the development of diabetic retinopathy. CONCLUSIONS: Undetectable beta-cell function within 10 yr of the onset of type 1 diabetes is associated with the earlier occurrence of diabetic retinopathy.
No takes yet. Share an insight, caveat, or question.
Nakanishi et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: